Th17 cells enhance viral persistence and inhibit T cell cytotoxicity in a model of chronic virus infection
Th17 cells enhance viral persistence and inhibit T cell cytotoxicity in a model of chronic virus infection
Hou, W., et al. 2009. J. Exp Med. 206, 313-328
Speaker: Jhen-Yu Ke (柯貞妤) Time:15:00~16:00, May 6, 2009
Commentator: Dr. Yao Chang (張 堯 老師) Place: Room 601
Abstract:
Infection with viruses that have the capacity to modulate or evade the immune response can result in persistency, which can lead to a variety of chronic diseases1. During viral persistency, the balance between the virus and the host immune response is crucial. However,in the pathogenesis of persistent viral infection, the role of IL-17-producing CD4+ T helper (Th17) cells, which can protect host from bacterial or fungal infections2, remains unknown. In this paper, the authors found that chronic Theiler’s murine encephalomyelitis virusinfection in vitro and in vivo favored Th17 development in an IL-6-dependent manner. The experimental result of anti-IL-17 antibody treatment indicated that Th17 cells secrete IL-17 to promote persistent viral infection and induce the pathogenesis of chronic demyelinating disease. IL-17 enhances inflammatory responses by amplifying virus-induced production of inflammatory cytokines and protects against infection-induced cell apoptosis by up-regulating the expression of antiapoptotic molecules. One interesting finding in this study is that IL-17 impairs antiviral cytotoxic CD8+ T cell responses resulting in enhanced viral replication and persistency. Collectively, these observations show the novel pathogenic role of Th17 cells and IL-17 in the persistency of Theiler’s murine encephalomyelitis virus infection.This particular interaction may also potentially operate in other chronic viral infections and could be a target for therapeutic involvement.
References:
1. Trottier, M., et al. 2004. Transition from acute to persistent Theiler’s virus infection requires active viral replication that drives proinflammatory cytokine expression and chronic demyelinating disease. J. Virol. 78, 12480-12488
2. Bettelli, E., et al. 2008. Induction and effector functions of T(H)17 cells. Nature 453, 1051-1057
